Garrison Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.6M | Sell |
28,345
-1,399
| -5% | -$261K | 2.84% | 4 |
|
|
2024
Q2 | $5.1M | Sell |
29,744
-148
| -0.5% | -$24.5K | 2.68% | 6 |
|
|
2024
Q1 | $5.44M | Sell |
29,892
-502
| -2% | -$86.5K | 2.86% | 6 |
|
|
2023
Q4 | $4.71M | Sell |
30,394
-607
| -2% | -$88.5K | 2.6% | 8 |
|
|
2023
Q3 | $4.62M | Sell |
31,001
-413
| -1% | -$60.6K | 2.82% | 5 |
|
|
2023
Q2 | $4.23M | Buy |
31,414
+315
| +1% | +$46.2K | 2.54% | 10 |
|
|
2023
Q1 | $4.96M | Sell |
31,099
-420
| -1% | -$64.2K | 3.07% | 2 |
|
|
2022
Q4 | $5.09M | Sell |
31,519
-703
| -2% | -$108K | 3.29% | 2 |
|
|
2022
Q3 | $4.33M | Sell |
32,222
-292
| -0.9% | -$41.9K | 3.05% | 2 |
|
|
2022
Q2 | $4.98M | Sell |
32,514
-513
| -2% | -$78.4K | 3.34% | 2 |
|
|
2022
Q1 | $5.35M | Sell |
33,027
-468
| -1% | -$68K | 3.02% | 3 |
|
|
2021
Q4 | $4.54M | Buy |
33,495
+56
| +0.2% | +$6.62K | 2.47% | 9 |
|
|
2021
Q3 | $3.61M | Buy |
33,439
+296
| +0.9% | +$33.8K | 2.19% | 13 |
|
|
2021
Q2 | $3.73M | Buy |
33,143
+383
| +1% | +$43.1K | 2.26% | 12 |
|
|
2021
Q1 | $3.54M | Buy |
32,760
+120
| +0.4% | +$12.8K | 2.26% | 12 |
|
|
2020
Q4 | $3.5M | Sell |
32,640
-22,587
| -41% | -$2.17M | 2.41% | 10 |
|
|
2020
Q3 | $4.84M | Buy |
55,227
+39
| +0.1% | +$3.67K | 2.55% | 9 |
|
|
2020
Q2 | $5.42M | Sell |
55,188
-519
| -0.9% | -$45.7K | 3.05% | 5 |
|
|
2020
Q1 | $4.24M | Buy |
55,707
+1,105
| +2% | +$94.1K | 2.87% | 5 |
|
|
2019
Q4 | $4.83M | Buy |
54,602
+30
| +0.1% | +$2.49K | 2.38% | 10 |
|
|
2019
Q3 | $4.13M | Sell |
54,572
-1,146
| -2% | -$78.6K | 2.14% | 15 |
|
|
2019
Q2 | $4.05M | Buy |
55,718
+90
| +0.2% | +$7.07K | 2.11% | 15 |
|
|
2019
Q1 | $4.48M | Buy |
55,628
+186
| +0.3% | +$15.2K | 2.37% | 10 |
|
|
2018
Q4 | $5.11M | Sell |
55,442
-2,059
| -4% | -$181K | 3.02% | 3 |
|
|
2018
Q3 | $5.44M | Sell |
57,501
-3,076
| -5% | -$292K | 2.69% | 5 |
|
|
2018
Q2 | $5.61M | Buy |
60,577
+1,457
| +2% | +$142K | 2.83% | 4 |
|
|
2018
Q1 | $5.6M | Sell |
59,120
-6,880
| -10% | -$756K | 3.13% | 1 |
|
|
2017
Q4 | $6.38M | Sell |
66,000
-5,653
| -8% | -$533K | 3.34% | 1 |
|
|
2017
Q3 | $6.37M | Sell |
71,653
-2,781
| -4% | -$212K | 3.57% | 1 |
|
|
2017
Q2 | $5.4M | Sell |
74,434
-1,321
| -2% | -$88.8K | 3.13% | 1 |
|
|
2017
Q1 | $4.94M | Sell |
75,755
-600
| -0.8% | -$37.7K | 2.91% | 1 |
|
|
2016
Q4 | $4.78M | Buy |
76,355
+329
| +0.4% | +$20.1K | 2.97% | 1 |
|
|
2016
Q3 | $4.79M | Sell |
76,026
-620
| -0.8% | -$40.1K | 3.08% | 1 |
|
|
2016
Q2 | $4.75M | Buy |
76,646
+455
| +0.6% | +$27.7K | 3.17% | 1 |
|
|
2016
Q1 | $4.35M | Sell |
76,191
-5,415
| -7% | -$302K | 3.05% | 1 |
|
|
2015
Q4 | $4.83M | Buy |
81,606
+1,070
| +1% | +$61.6K | 3.33% | 1 |
|
|
2015
Q3 | $4.38M | Sell |
80,536
-424
| -0.5% | -$27.6K | 3.2% | 1 |
|
|
2015
Q2 | $5.44M | Sell |
80,960
-2,556
| -3% | -$167K | 3.66% | 1 |
|
|
2015
Q1 | $4.89M | Buy |
83,516
+16,785
| +25% | +$1.01M | 3.24% | 1 |
|
|
2014
Q4 | $3.85M | Hold |
66,731
| – | – | 2.89% | 1 |
|
|
2014
Q3 | $3.85M | Sell |
66,731
-215
| -0.3% | -$11.9K | 2.89% | 1 |
|
|
2014
Q2 | $3.78M | Sell |
66,946
-1,885
| -3% | -$98.9K | 2.73% | 1 |
|
|
2014
Q1 | $3.54M | Buy |
68,831
+3,556
| +5% | +$180K | 2.77% | 1 |
|
|
2013
Q4 | $3.45M | Sell |
65,275
-327
| -0.5% | -$16.1K | 2.81% | 1 |
|
|
2013
Q3 | $2.93M | Buy |
65,602
+874
| +1% | +$38.7K | 2.56% | 4 |
|
|
2013
Q2 | $2.68M | Buy |
+64,728
| New | +$2.83M | 2.49% | 4 |
|
Other funds holding ABBV
Garrison Asset Management's ABBV Position: Q3 2024 in Review
Garrison Asset Management reduced its AbbVie (ABBV) stake by 4.7% in Q3 2024, selling an estimated $261K and leaving 28,345 shares worth $5.6M. The position accounts for 2.84% of the portfolio, ranked #4.
Garrison Asset Management first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.38M in Q4 2017. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Garrison Asset Management held 28,345 shares of AbbVie worth $5.6M as of Q3 2024.
- Garrison Asset Management sold 1,399 AbbVie shares in Q3 2024, an estimated $261K.
- AbbVie made up 2.84% of Garrison Asset Management's portfolio in Q3 2024, its #4 holding.
- Garrison Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
- Garrison Asset Management's AbbVie position peaked at $6.38M in Q4 2017.
- 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Garrison Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.